首頁 > 市場調查報告書 > 醫療設備

生技設備

HLA 打字全球市場研究報告——2023-2030 年行業分析、規模、份額、增長、趨勢和預測

市場調查報告書

商品編碼

1267323

HLA 打字全球市場研究報告——2023-2030 年行業分析、規模、份額、增長、趨勢和預測

Global HLA Typing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年04月01日 | 出版商:

Value Market Research | 英文 241 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計全球 HLA 分型市場需求將從 2022 年的 510 萬美元增長到 2030 年的近 1079 萬美元，2023-2030 年研究期間的複合年增長率為 9.82%。 .

HLA 分型是一項實驗室測試，用於確定個體的人類白細胞抗原 (HLA) 類型。該測試通常使用少量血液樣本進行，需要專門的技術來識別和分析樣本中的特定 HLA 蛋白。 HLA 分型通常用於器官移植以確定潛在的供體和受體是否相容。它還用於輸血和診斷某些自身免疫性疾病。

市場動態：

HLA 分型的興起是由於越來越多地使用器官移植作為一種醫療實踐。隨著器官移植變得越來越普遍和成功，對可靠和準確的 HLA 分型的需求也在增加。此外，HLA 分型在診斷和治療自身免疫性疾病方面的應用可能會推動市場增長。此外，HLA 分型被用於通過盡可能接近地匹配供體和受體血液來確保輸血的安全性和有效性，這可能會促進市場增長。然而，檢查過程的成本和復雜性可能會阻礙市場增長。

研究報告描述了波特的五力模型、市場吸引力分析和價值鏈分析。這些工具可幫助您清楚地了解您的行業結構並評估您在全球範圍內的競爭吸引力。此外，這些工具還能夠全面評估全球 hla 打字市場的每個細分市場。 hla 打字行業的增長和趨勢為這項研究提供了一個整體的方法。

市場細分：

本部分提供了按國家和地區劃分的細分市場的詳細數據，以幫助確定每種產品或服務的目標受眾和未來商機。

按產品

儀器
試劑和耗材
軟件與服務

按申請

診斷
調查

通過技術

分子檢測
基於序列的分子檢測
非分子檢測

由最終用戶

商業服務提供商
醫院和移植中心
調查研究機構和學術機構

按地區分析：

本節介紹了區域前景，重點關注北美、歐洲、亞太地區、拉丁美洲、中東和非洲 HLA 分型市場當前和未來的需求。此外，我們還關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的綜合概況和全球競爭格局的詳細視圖。 hla 打字市場的主要參與者是 Thermo Fisher Scientific Inc.、Bio-Rad Laboratories Inc.、Qiagen N.V.、Omixon Inc.、GenDx、Illumina Inc.、TBG Diagnostics Limited、Dickinson and Company、Takara Bio Inc.、F. Hoffmann- Laroche 我們是太平洋生物科技有限公司本節包括對競爭格局的全面了解，包括各種戰略發展，例如主要併購、未來能力、合作夥伴關係、財務概覽、合作、新產品開發和新產品發布。

內容

第一章前言

報告內容
- 目的
- 目標受眾
- USP（獨特的銷售建議）及其提供的內容
調查範圍
調查方法
- 市場調研流程
- 市場研究方法

第 2 章執行摘要

市場亮點
全球市場概況

第 3 章 HLA 分型 - 行業分析

簡介 - 市場動態
市場驅動力
市場製約因素
機會
行業趨勢
波特的五力分析
市場吸引力分析
- 按產品分類的市場吸引力分析
- 市場吸引力分析：按應用
- 按技術進行市場吸引力分析
- 最終用戶的市場吸引力分析
- 市場吸引力分析：按地區

第四章價值鏈分析

價值鏈分析
原材料分析
- 原材料清單
- 原材料製造商列表
- 主要原材料價格走勢
潛在買家名單
營銷渠道
- 直接營銷
- 間接營銷
- 市場發展趨勢

第 5 章 COVID-19 爆發的影響分析

第 6 章 HLA 分型全球市場分析：按產品類型

產品概覽
過去和未來的數據
按產品分析
儀器
試劑和耗材
軟件與服務

第 7 章 HLA 分型全球市場分析：按應用

總結：按應用
過去和未來的數據
分析：按應用
診斷
調查

第 8 章 Hla 打字全球市場分析：按技術

技術概述
過去和未來的數據
技術分析
分子檢測
基於序列的分子檢測
非分子檢測

第 9 章 Hla 打字全球市場分析：按最終用戶

最終用戶總結
過去和未來的數據
最終用戶分析
商業服務提供商
醫院和移植中心
調查研究機構和學術機構

第 10 章 Hla 打字全球市場分析：按地區

區域展望
介紹
北美銷售分析
- 概覽、歷史和預測銷售分析
- 北美各部門的銷售分析
- 北美銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史和預測銷售分析
- 按細分市場進行的歐洲銷售分析
- 按國家/地區劃分的歐洲銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 意大利銷售分析
- 俄羅斯銷售分析
- 其他歐洲銷售分析
亞太地區銷售分析
- 概覽、歷史和預測銷售分析
- 亞太地區各部門的銷售分析
- 亞太國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本的銷售分析
- 韓國銷售分析
- 澳大利亞銷售分析
- 其他亞太地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史和預測銷售分析
- 拉丁美洲各部門的銷售分析
- 拉丁美洲國家/地區的銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利的銷售分析
- 其他拉丁美洲銷售分析
中東和非洲銷售分析
- 概覽、歷史和預測銷售分析
- 中東和非洲各細分市場的銷售額分析
- 中東和非洲國家/地區的銷售分析
- 沙特阿拉伯銷售分析
- 阿聯酋銷售分析
- 以色列銷售分析
- 南非銷售分析
- 其他中東和非洲銷售分析

第11章HLA分型公司的競爭格局

草裙舞打字市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他擴展

第12章公司簡介

頂級公司份額分析
市場集中度
Thermo Fisher Scientific Inc.
- 公司概況
- 企業收入
- 產品介紹
- 近期趨勢
Bio-Rad 實驗室公司
- 公司概況
- 企業收入
- 產品介紹
- 近期趨勢
Qiagen N.V.
- 公司概況
- 企業收入
- 產品介紹
- 近期趨勢
Omixon 公司
- 公司概況
- 企業收入
- 產品介紹
- 近期趨勢
GenDx
- 公司概況
- 企業收入
- 產品介紹
- 近期趨勢
因美納公司
- 公司概況
- 企業收入
- 產品介紹
- 近期趨勢
TBG 診斷有限公司
- 公司概況
- 企業收入
- 產品介紹
- 近期趨勢
狄金森公司
- 公司概況
- 企業收入
- 產品介紹
- 近期趨勢
Takara Bio Inc.
- 公司概況
- 企業收入
- 產品介紹
- 近期趨勢
F. Hoffman-La Roche Limited
- 公司概況
- 企業收入
- 產品介紹
- 近期趨勢
太平洋生物科學
- 公司概況
- 企業收入
- 產品介紹
- 近期趨勢

注意：在公司簡介、財務細節、近期發展等方面，基於可用信息，私人控股公司可能不包括在內。

簡介目錄圖表

Product Code: VMR112110056

The global demand for HLA Typing Market is presumed to reach the market size of nearly USD 10.79 MN by 2030 from USD 5.1 MN in 2022 with a CAGR of 9.82% under the study period 2023 - 2030.

HLA typing is a laboratory test that is used to determine an individual's human leukocyte antigen (HLA) type. The test is usually performed using a small blood sample, and it involves the use of specialized techniques to identify and analyze the specific HLA proteins present in the sample. HLA typing is typically used for organ transplantation, as it helps to determine whether a potential donor and recipient are a good match. It is also used in blood transfusions and the diagnosis of certain autoimmune diseases.

Market Dynamics:

The rise of HLA typing has been driven by the increasing use of organ transplantation as a medical treatment. As organ transplantation has become more common and successful, the need for reliable and accurate HLA typing has increased. Moreover, the usefulness of HLA typing in diagnosing and treating autoimmune diseases may drive market growth. Furthermore, HLA typing is used to ensure that blood transfusions are safe and effective by matching the blood of the donor and recipient as closely as possible, which may boost the market's growth. However, the cost and complexity of the testing process may impede market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of hla typing. The growth and trends of hla typing industry provide a holistic approach to this study.

Market Segmentation:

This section of the hla typing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Instruments
Reagents & Consumables
Software & Services

By Application

Diagnosis
Research

By Technique

Molecular Assay
Sequenced-Based Molecular Assay
Non-Molecular Assay

By End-User

Commercial Service Providers
Hospitals And Transplant Centers
Research Labs & Academic Institutes

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the HLA Typing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the hla typing market include Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Omixon Inc., GenDx, Illumina Inc., TBG Diagnostics Limited, Dickinson and Company, Takara Bio Inc., F. Hoffman-La Roche Limited, Pacific Biosciences. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . HLA TYPING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Technique
- 3.7.4 Market Attractiveness Analysis By End-user
- 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL HLA TYPING MARKET ANALYSIS BY PRODUCT

6.1 Overview by Product
6.2 Historical and Forecast Data
6.3 Analysis by Product
6.4 Instruments Historic and Forecast Sales by Regions
6.5 Reagents & Consumables Historic and Forecast Sales by Regions
6.6 Software & Services Historic and Forecast Sales by Regions

7 . GLOBAL HLA TYPING MARKET ANALYSIS BY APPLICATION

7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Diagnosis Historic and Forecast Sales by Regions
7.5 Research Historic and Forecast Sales by Regions

8 . GLOBAL HLA TYPING MARKET ANALYSIS BY TECHNIQUE

8.1 Overview by Technique
8.2 Historical and Forecast Data
8.3 Analysis by Technique
8.4 Molecular Assay Historic and Forecast Sales by Regions
8.5 Sequenced-based Molecular Assay Historic and Forecast Sales by Regions
8.6 Non-Molecular Assay Historic and Forecast Sales by Regions

9 . GLOBAL HLA TYPING MARKET ANALYSIS BY END-USER

9.1 Overview by End-user
9.2 Historical and Forecast Data
9.3 Analysis by End-user
9.4 Commercial Service Providers Historic and Forecast Sales by Regions
9.5 Hospitals And Transplant Centers Historic and Forecast Sales by Regions
9.6 Research Labs & Academic Institutes Historic and Forecast Sales by Regions

10 . GLOBAL HLA TYPING MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1. Overview, Historic and Forecast Sales Analysis
- 10.3.2. North America By Segment Sales Analysis
- 10.3.3. North America By Country Sales Analysis
- 10.3.4. United State Sales Analysis
- 10.3.5. Canada Sales Analysis
- 10.3.6. Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1. Overview, Historic and Forecast Sales Analysis
- 10.4.2. Europe by Segment Sales Analysis
- 10.4.3. Europe by Country Sales Analysis
- 10.4.4. United Kingdom Sales Analysis
- 10.4.5. France Sales Analysis
- 10.4.6. Germany Sales Analysis
- 10.4.7. Italy Sales Analysis
- 10.4.8. Russia Sales Analysis
- 10.4.9. Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1. Overview, Historic and Forecast Sales Analysis
- 10.5.2. Asia Pacific by Segment Sales Analysis
- 10.5.3. Asia Pacific by Country Sales Analysis
- 10.5.4. China Sales Analysis
- 10.5.5. India Sales Analysis
- 10.5.6. Japan Sales Analysis
- 10.5.7. South Korea Sales Analysis
- 10.5.8. Australia Sales Analysis
- 10.5.9. Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1. Overview, Historic and Forecast Sales Analysis
- 10.6.2. Latin America by Segment Sales Analysis
- 10.6.3. Latin America by Country Sales Analysis
- 10.6.4. Brazil Sales Analysis
- 10.6.5. Argentina Sales Analysis
- 10.6.6. Peru Sales Analysis
- 10.6.7. Chile Sales Analysis
- 10.6.8. Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1. Overview, Historic and Forecast Sales Analysis
- 10.7.2. Middle East & Africa by Segment Sales Analysis
- 10.7.3. Middle East & Africa by Country Sales Analysis
- 10.7.4. Saudi Arabia Sales Analysis
- 10.7.5. UAE Sales Analysis
- 10.7.6. Israel Sales Analysis
- 10.7.7. South Africa Sales Analysis
- 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE HLA TYPING COMPANIES

11.1. Hla Typing Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12 . COMPANY PROFILES OF HLA TYPING INDUSTRY

12.1. Top Company Share Analysis
12.2. Market Concentration Rate
12.3. Thermo Fisher Scientific Inc.
- 12.3.1. Company Overview
- 12.3.2. Company Revenue
- 12.3.3. Products
- 12.3.4. Recent Developments
12.4. Bio-Rad Laboratories Inc.
- 12.4.1. Company Overview
- 12.4.2. Company Revenue
- 12.4.3. Products
- 12.4.4. Recent Developments
12.5. Qiagen N.V.
- 12.5.1. Company Overview
- 12.5.2. Company Revenue
- 12.5.3. Products
- 12.5.4. Recent Developments
12.6. Omixon Inc.
- 12.6.1. Company Overview
- 12.6.2. Company Revenue
- 12.6.3. Products
- 12.6.4. Recent Developments
12.7. GenDx
- 12.7.1. Company Overview
- 12.7.2. Company Revenue
- 12.7.3. Products
- 12.7.4. Recent Developments
12.8. Illumina Inc.
- 12.8.1. Company Overview
- 12.8.2. Company Revenue
- 12.8.3. Products
- 12.8.4. Recent Developments
12.9. TBG Diagnostics Limited
- 12.9.1. Company Overview
- 12.9.2. Company Revenue
- 12.9.3. Products
- 12.9.4. Recent Developments
12.10. Dickinson and Company
- 12.10.1. Company Overview
- 12.10.2. Company Revenue
- 12.10.3. Products
- 12.10.4. Recent Developments
12.11. Takara Bio Inc.
- 12.11.1. Company Overview
- 12.11.2. Company Revenue
- 12.11.3. Products
- 12.11.4. Recent Developments
12.12. F. Hoffman-La Roche Limited
- 12.12.1. Company Overview
- 12.12.2. Company Revenue
- 12.12.3. Products
- 12.12.4. Recent Developments
12.13. Pacific Biosciences
- 12.13.1. Company Overview
- 12.13.2. Company Revenue
- 12.13.3. Products
- 12.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

簡介目錄圖表